FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310109043> ?p ?o ?g. }

• W4310109043 endingPage "8370" @default.
• W4310109043 startingPage "8368" @default.
• W4310109043 abstract "Introduction: Heparin induced thrombocytopenia (HIT) and APS (antiphospholipid syndrome) are acquired thrombophilia's characterized by both arterial and venous thromboembolic events (TE). As a common feature APS and HIT share the presence of pathological antibodies, which play a crucial role in disease pathogenesis. In HIT, antibodies are directed to platelet factor (PF) 4 and heparin, respectively, and in APS, antibodies target anti-phospholipids (anti-cardiolipin antibody, anti-Beta2- glycoprotein I and lupus anticoagulant). There is growing evidence that complement- and neutrophil activation in the form of neutrophil extracellular traps (NETs) play an important role in the pathogenesis of thrombosis, the so-called immunothrombosis. Insufficient control with subsequent unrestrained complement activation results in thrombosis as seen in patients with paroxysmal nocturnal hemoglobinuria (PNH). Therapeutic inhibition of complement activation abrogates thrombosis in these patients, emphasizing the important role of complement activation in the pathogenesis of thrombosis. It has been demonstrated, that complement activation products efficiently induce neutrophil activation, and therapeutic complement inhibition in sepsis and PNH prevents neutrophil activation. Here, we investigate the role of complement activation and neutrophil activation in patients with APS and HIT, respectively. Methods To assess the association of complement activation and NET Formation, we measured complement activation products (C4bc, C3bc) and marks for neutrophil activation, such as nucleosomes and human neutrophil elastase-α1- antitrypsin complexes (HNE) by ELISA in plasma of 34 primary APS- and 26 HIT- patients and 31 healthy controls. Groups have been compared using the Mann- Whitney-Rank Test. Values are indicated as median and range, p<0.05 is considered statistically significant. Results Patients with APS and HIT showed sign. higher levels of complement activation products as compared to healthy controls. Complement activation mainly of the classical (C4b/c) and alternate pathway (C3b/c) in APS (11 nM and 263 nM) and in HIT (33 nM and 324 nM) were sign. higher (p<0.0001) as compared to the healthy controls (7 nM and 19 nM). C4bc levels were sign. higher in HIT as compared to APS patients (p<0001), but there was no difference in C3b/c levels between these two groups (see figure 1). Patients with HIT had a sig. (p<0.0001) higher nucleosomes (440 U/ml) and HNE (121 ng/ml) as compared to healthy controls (12 U/ml and 26 ng/ml). HNE levels were sign. (p<0.001) higher in APS patients (37 ng/ml) as compared to healthy controls (26 ng/ml), however no difference was observed in nucleosome levels (12 U/ml vs 14 U/ml) (see figure 2). Based on the number of positive antibodies, eleven APS patients have been stratified as high-risk and 24 APS patients as low- to intermediate risk. C4bc levels were sign. increased in the high-risk patients as compared to the low- to intermediate risk group, whereas no difference in C3b/c levels could be observed between the 2 groups. Similarly, HNE complexes sign. increased in the high-risk patients as compared to the low- to intermediate risk group, whereas no difference in nucleosome levels could be observed between the 2 groups. Six HIT patients (22%) had a diagnosed TE event whereas 17 patients (63%) had no diagnosed TE. In four patients (15%) no clinical data were available, and they have been excluded from subgroup analysis. Interestingly, the measured markers for complement - and neutrophil activation in HIT patient with and without thrombosis were not different. Conclusions We demonstrate complement activation in patients with HIT and APS. Based on the simultaneous raise in nucleosomes and HNE, there is evidence of NET formation in HIT, whereas only weak neutrophil activation can be found in APS. In APS classical complement activation and neutrophil activation correlates with APS risk stratification. Our results demonstrate classical complement pathway- and neutrophil activation in HIT and APS patients. These findings may form the base for new therapeutic strategies targeting complement and neutrophil activation. Figure 1View largeDownload PPTFigure 1View largeDownload PPT Close modal" @default.
• W4310109043 created "2022-11-30" @default.
• W4310109043 creator A5035445211 @default.
• W4310109043 creator A5037467883 @default.
• W4310109043 creator A5048171474 @default.
• W4310109043 creator A5064802484 @default.
• W4310109043 creator A5075084979 @default.
• W4310109043 creator A5079300413 @default.
• W4310109043 creator A5080818853 @default.
• W4310109043 creator A5083717598 @default.
• W4310109043 creator A5085380635 @default.
• W4310109043 creator A5087837075 @default.
• W4310109043 date "2022-11-15" @default.
• W4310109043 modified "2023-10-16" @default.
• W4310109043 title "A Role of Immunothrombosis in Acquired Antibody-Mediated Thrombophilia's: Classical Complement and Neutrophil Activation in APS and HIT" @default.
• W4310109043 doi "https://doi.org/10.1182/blood-2022-164592" @default.
• W4310109043 hasPublicationYear "2022" @default.
• W4310109043 type Work @default.
• W4310109043 citedByCount "0" @default.
• W4310109043 crossrefType "journal-article" @default.
• W4310109043 hasAuthorship W4310109043A5035445211 @default.
• W4310109043 hasAuthorship W4310109043A5037467883 @default.
• W4310109043 hasAuthorship W4310109043A5048171474 @default.
• W4310109043 hasAuthorship W4310109043A5064802484 @default.
• W4310109043 hasAuthorship W4310109043A5075084979 @default.
• W4310109043 hasAuthorship W4310109043A5079300413 @default.
• W4310109043 hasAuthorship W4310109043A5080818853 @default.
• W4310109043 hasAuthorship W4310109043A5083717598 @default.
• W4310109043 hasAuthorship W4310109043A5085380635 @default.
• W4310109043 hasAuthorship W4310109043A5087837075 @default.
• W4310109043 hasBestOaLocation W43101090431 @default.
• W4310109043 hasConcept C104317684 @default.
• W4310109043 hasConcept C111684460 @default.
• W4310109043 hasConcept C112313634 @default.
• W4310109043 hasConcept C126322002 @default.
• W4310109043 hasConcept C127716648 @default.
• W4310109043 hasConcept C159654299 @default.
• W4310109043 hasConcept C188082640 @default.
• W4310109043 hasConcept C203014093 @default.
• W4310109043 hasConcept C2780842393 @default.
• W4310109043 hasConcept C2780868729 @default.
• W4310109043 hasConcept C54355233 @default.
• W4310109043 hasConcept C71924100 @default.
• W4310109043 hasConcept C86803240 @default.
• W4310109043 hasConceptScore W4310109043C104317684 @default.
• W4310109043 hasConceptScore W4310109043C111684460 @default.
• W4310109043 hasConceptScore W4310109043C112313634 @default.
• W4310109043 hasConceptScore W4310109043C126322002 @default.
• W4310109043 hasConceptScore W4310109043C127716648 @default.
• W4310109043 hasConceptScore W4310109043C159654299 @default.
• W4310109043 hasConceptScore W4310109043C188082640 @default.
• W4310109043 hasConceptScore W4310109043C203014093 @default.
• W4310109043 hasConceptScore W4310109043C2780842393 @default.
• W4310109043 hasConceptScore W4310109043C2780868729 @default.
• W4310109043 hasConceptScore W4310109043C54355233 @default.
• W4310109043 hasConceptScore W4310109043C71924100 @default.
• W4310109043 hasConceptScore W4310109043C86803240 @default.
• W4310109043 hasIssue "Supplement 1" @default.
• W4310109043 hasLocation W43101090431 @default.
• W4310109043 hasOpenAccess W4310109043 @default.
• W4310109043 hasPrimaryLocation W43101090431 @default.
• W4310109043 hasRelatedWork W2036126415 @default.
• W4310109043 hasRelatedWork W2036128302 @default.
• W4310109043 hasRelatedWork W2043396131 @default.
• W4310109043 hasRelatedWork W2083566103 @default.
• W4310109043 hasRelatedWork W2122760156 @default.
• W4310109043 hasRelatedWork W2143624722 @default.
• W4310109043 hasRelatedWork W2183444144 @default.
• W4310109043 hasRelatedWork W2398179880 @default.
• W4310109043 hasRelatedWork W2415726847 @default.
• W4310109043 hasRelatedWork W2810035127 @default.
• W4310109043 hasVolume "140" @default.
• W4310109043 isParatext "false" @default.
• W4310109043 isRetracted "false" @default.
• W4310109043 workType "article" @default.